NCT01058174View on ClinicalTrials.gov

Liver Transplant European Study Into the Prevention of Fungal Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

December 15, 2009

Primary Completion Date

May 3, 2012

Study Completion Date

May 3, 2012

Conditions
Liver TransplantationMycoses
Interventions
DRUG

micafungin

intravenous infusion

DRUG

fluconazole

intravenous infusion

DRUG

liposomal amphotericin B

intravenous infusion

DRUG

caspofungin

intravenous infusion

Trial Locations (36)

4

Dublin

1070

Brussels

1082

Budapest

1200

Brussels

2650

Antwerp

6020

Innsbruck

9000

Ghent

10126

Torino

13353

Berlin

14004

Córdoba

14186

Stockholm

15706

Santiago de Compostela

20146

Milan

20246

Hamburg

22328

Bucharest

28007

Madrid

28034

Madrid

30625

Hanover

31059

Toulouse

32110

Clichy

33100

Udine

35127

Padua

46009

Valencia

48903

Barakald

69120

Heidelberg

75013

Paris

94804

Paris

123182

Moscow

129090

Moscow

197758

Saint Petersburg

3000-075

Coimbra

4099-001

Porto

Unknown

Riyadh

08036

Barcelona

B15 2TH

Birmingham

SE5 9RS

London

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01058174 - Liver Transplant European Study Into the Prevention of Fungal Infection | Biotech Hunter | Biotech Hunter